In this episode of Nutrition Asia, two firms specialising in kids’ supplements – Life-Space and Nutritional Growth Solutions – have revealed their R&D priorities, including probiotics, personalised nutrition, and protein shakes for active children.
Hong Kong-listed nutrition giant Health & Happiness has unveiled how it plans to expand its Swisse and Biostime brands globally, after unveiling full-year revenue growth of 2.5 per cent revenue growth.
Australian health and nutrition company ATP Science is branching into the FMCG space with the launch of a range of high protein, low calorie, low sugar ice-cream, plus venturing into practitioner-only supplements for gut health.
In this round-up, we look at how Japanese health and wellness retailer Welcia-BHG plans to expand its presence in Singapore, GN Corporation's clinical trial on using beta glucan as an adjunct treatment for COVID-19 treatment and more.
Japanese health supplement, personal care and beauty product retailer Welcia-BHG is on track to expand its offline presence in Singapore, with five new stores planned for this year, despite concerns on how COVID-19 could affect foot traffic.
Bened Biomedical is making inroads into the study of psychobiotics as it embarks on a human clinical trial that looks at its flagship strain Lactobacillus plantarum PS128 on Tourette syndrome and Rett syndrome.
About 10 per cent of complementary medicines in Australia did not manage to transit to the new list of health indications permitted by the Therapeutic Goods Administration (TGA) and have been cancelled.
In this round-up, we shine the spotlight on trends across APAC’s health and nutrition market, including the use of BCAA-leucine, astaxanthin for muscle health in elderly, clean nutrition trends in India, and the rise of ‘light and strong’ functional foods...
China vitamin and dietary supplement (VDS) firm BY-HEALTH says the country’s health foods market is increasingly diverging between either foods/snacks with ‘light’ functionalities or supplements with ‘strong’ functionalities, as it unveiled 15% revenue...
Probiotics that address inflammation, diabetes, and muscle health received the largest percentage growth in terms of the number of consumer reviews globally last year, showing growing interest amongst consumers in these types of products.
BASF has received approval from the Therapeutic Goods Administration (TGA) in Australia to supply a human milk oligosaccharide ingredient, 2’Fucosyllactose (2’-FL), for use as a prebiotic in dietary supplements in Australia.
OptiBiotix Health will start distributing its blood pressure and cholesterol lowering probiotic in Asia Pacific this year, with heart health concerns rising on the back of changing dietary and lifestyle patterns in the region.